Estimates based on drug properties and standard treatment parameters.
108.0 mL/min
Highly Dialyzable
Significant removal expected. Half-life: 2 h (35% of the drug enters enterohepatic recirculation). Consider post-dialysis supplementation.
Data Used:
✅
molar_mass, mw_factor, half_life
⚠️ Missing:
protein_binding, vd
Free fraction:
0.5
Mw factor:
1
Vd factor:
0.8
Hl factor:
1
Half life:
2 h (35% of the drug enters enterohepatic recirculation)
Half life category:
Short (1-4h)
3.1 mL/min
Low PD Clearance
Minimal removal expected. No supplementation needed. Half-life: 2 h (35% of the drug enters enterohepatic recirculation).
Data Used:
✅
molar_mass, half_life
⚠️ Missing:
protein_binding
Free fraction:
0.5
Half life:
2 h (35% of the drug enters enterohepatic recirculation)
Half life category:
Short (1-4h)
Unable to Assess
Insufficient data for TPE risk assessment. Protein binding and Vd required.
Data Used:
✅
half_life
⚠️ Missing:
protein_binding, vd
Half life:
2 h (35% of the drug enters enterohepatic recirculation)
Half life category:
Short (1-4h)
Cannot Assess
Vd data required for hemoadsorption effectiveness assessment.
Data Used:
✅
half_life
⚠️ Missing:
vd
Half life:
2 h (35% of the drug enters enterohepatic recirculation)
Half life category:
Short (1-4h)
